296
Views
9
CrossRef citations to date
0
Altmetric
Research Article

In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures

, , , &
Pages 1651-1662 | Received 31 May 2012, Accepted 07 Sep 2012, Published online: 24 Oct 2012

References

  • Zhang O. (2001). Cellulose associative thickeners. Carbohydr Polym, 45:1–10.
  • Pekel N, Yoshii F, Kume T, Güven O. (2004). Radiation crosslinking of biodegradable hydroxypropylmethylcellulose. Carbohydr Polym, 55:139–147.
  • Oh SY, Yoo DI, Shin Y, Kim HC, Kim HY, Chung YS et al. (2005). Crystalline structure analysis of cellulose treated with sodium hydroxide and carbon dioxide by means of X-ray diffraction and FTIR spectroscopy. Carbohydr Res, 340:2376–2391.
  • Kamel S, Ali N, Jahangir K, Shah SM, El-Gendy AA. (2008). Pharmaceutical significance of cellulose: a review. eXpress Polym Letters, 2:758–778.
  • Hardy IJ, Cook WG, Melia CD. (2006). Compression and compaction properties of plasticised high molecular weight hydroxypropylmethylcellulose (HPMC) as a hydrophilic matrix carrier. Int J Pharm, 311:26–32.
  • Ghimire M, Hodges LA, Band J, O’Mahony B, McInnes FJ, Mullen AB et al. (2010). In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets. J Control Release, 147:70–75.
  • Nair LS, Laurencin CT. (2006). Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv Biochem Eng Biotechnol, 102:47–90.
  • Viridén A, Abrahmsén-Alami S, Wittgren B, Larsson A. (2011). Release of theophylline and carbamazepine from matrix tablets–consequences of HPMC chemical heterogeneity. Eur J Pharm Biopharm, 78:470–479.
  • Baumgartnera S, Lahajnarb G, Sepeb A, Kristl J. (2005). Quantitative evaluation of polymer concentration profile during swelling of hydrophilic matrix tablets using 1H NMR and MRI methods. Eur J Pharm Biopharm, 59:299–306.
  • Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
  • Siepmann J, Göpferich A. (2001). Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev, 48:229–247.
  • European Agency for the Evaluation of Medicinal Products (EMEA). Veterinary Medicines Evaluation Unit “Committee for Veterinary Medicinal Products” Ketoprofen. 1996, EMEA/MRL/076/96-Final. March.
  • Roda A, Sabatini L, Mirasoli M, Baraldini M, Roda E. (2002). Bioavailability of a new ketoprofen formulation for once-daily oral administration. Int J Pharm, 241:165–172.
  • Martindale. (2011). The Complete Drug Reference. 37th Edition. London: The Pharmaceutical Press.
  • Baveja SK, Ranga Rao KV, Padmalatha Devi K. (1987). Zero-order release hydrophilic matrix tablets of β-adrenergic blockers. Int J Pharm, 39:39–45.
  • Vázquez MJ, Gomes-Amoza JL, Martinez-Pacheco R, Souto C, Concheiro A. (1995). Relationships between drug dissolution profile and gelling agent viscosity in tablets prepared with hydropropylmethylcelluose (HPMC) and sodium carboxymethylcellulose (NaCMC) mixtures. Drug Dev Ind Pharm, 21:1859–1874.
  • Bettini R, Colombo P, Massimo G, Catellani PL, Vitali T. (1994). Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects. Eur J Pharm Sci, 2:213–219.
  • Rodriguez CF, Bruneau N, Barra J, Alfonso D, Doeker E. (2000). Hydrophilic cellulose derivatives as drug delivery carriers: influence of substitution type on the properties of compressed matrix tablets. In: Handbook of Pharmaceutical Controlled Release Technology. Wise DL, ed. New York/Basel: Marcel Dekker, 1–30.
  • Escudero JJ, Ferrero C, Casas M, Jiménez-Castellanos MR. (2012). Compaction properties, drug release kinetics and fronts movement studies of matrices combining mixtures of swellable and inert polymers. III: Effect of polymer substitution type. Int J Pharm, 434:215–223.
  • Batista de Carvalho LAE, Marques MPM, Tomkinson J. (2006). Drug-excipient interactions in ketoprofen: a vibrational spectroscopy study. Biopolymers, 82:420–424.
  • Bozdag-Pehlivan S, Subasi B, Vural I, Unlü N, Capan Y. (2011). Evaluation of drug-excipient interaction in the formulation of celecoxib tablets. Acta Pol Pharm, 68:423–433.
  • Liltorp K, Larsen TG, Willumsen B, Holm R. (2011). Solid state compatibility studies with tablet excipients using non thermal methods. J Pharm Biomed Anal, 55:424–428.
  • Chieng N, Rades T, Aaltonen J. (2011). An overview of recent studies on the analysis of pharmaceutical polymorphs. J Pharm Biomed Anal, 55:618–644.
  • Chieng N, Rehder S, Saville D, Rades T, Aaltonen J. (2009). Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction. J Pharm Biomed Anal, 49:18–25.
  • Vueba ML, Batista de Carvalho LAE, Veiga F, Sousa JJ, Pina ME. (2004). Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur J Pharm Biopharm, 58:51–59.
  • Vueba ML, Batista de Carvalho LAE, Veiga F, Sousa JJ, Pina ME. (2005). Role of cellulose ether polymers on ibuprofen release from matrix tablets. Drug Dev Ind Pharm, 31:653–665.
  • United States Pharmacopeia 34/The National Formulary 29. U.S.P. (2011). Convention, Rockville, USA.
  • Sood A, Panchagnula R. (1999). Role of dissolution studies in controlled release drug delivery systems. S.T. Pharma Sci, 9:157–168.
  • Huang YB, Tsai YH, Yang WC, Chang JS, Wu PC, Takayama K. (2004). Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur J Pharm Biopharm, 58:607–614.
  • Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
  • Marques MPM, Oliveira PJ, Moreno AJM, Batista de Carvalho LAE. (2002). Study of carvedilol by combined raman spectroscopy and ab initio MO calculations. J Raman Spectrosc, 33:778–783.
  • Vueba ML, Pina ME, Veiga F, Sousa JJ, de Carvalho LAE. (2006). Conformational study of ketoprofen by combined DFT calculations and Raman spectroscopy. Int J Pharm, 307:56–65.
  • Vueba ML, Pina ME, Batista de Carvalho LAE. (2008). Conformational stability of ibuprofen: assessed by DFT calculations and optical vibrational spectroscopy. J Pharm Sci, 97:845–859.
  • Santos JV, Pina ME, Marques MP, de Carvalho LAE. (2012). New sustained release of Zidovudine Matrix tablets - cytotoxicity toward Caco-2 cells. Drug Dev Ind Pharm.
  • Fechner PM, Wartewig S, Kiesow A, Heilmann A, Kleinebudde P, Neubert RH. (2005). Interaction of water with different cellulose ethers: a Raman spectroscopy and environmental scanning electron microscopy study. J Pharm Pharmacol, 57:689–698.
  • Langkilde FW, Svantesson A. (1995). Identification of celluloses with Fourier-transform (FT) mid-infrared, FT-Raman and near-infrared spectrometry. J Pharm Biomed Anal, 13:409–414.
  • Alvarez-Lorenzo C, Lorenzo-Ferreira RA, Gómez-Amoza JL, Martínez-Pacheco R, Souto C, Concheiro A. (1999). A comparison of gas-liquid chromatography, NMR spectroscopy and Raman spectroscopy for determination of the substituent content of general non-ionic cellulose ethers. J Pharm Biomed Anal, 20:373–383.
  • Ciolacu D, Ciolacu F, Popa VI. (2011). Amorphous cellulose – structure and characterization. Cellulose Chem Technol, 45:13–21.
  • Cirri M, Maestrelli F, Mennini N, Mura P. (2009). Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems. J Pharm Biomed Anal, 50:690–694.
  • Vueba ML, Veiga F, Sousa JJ, Pina ME. (2005). Compatibility studies between ibuprofen or ketoprofen with cellulose ether polymer mixtures using thermal analysis. Drug Dev Ind Pharm, 31:943–949.
  • Reynolds TD, Mitchell SA, Balwinski KM. (2002). Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Dev Ind Pharm, 28:457–466.
  • Ferrero C, Massuelle D, Doelker E. (2010). Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. J Control Release, 141:223–233.
  • Michailova V, Titeva S, Kotsilkova R, Krusteva E, Minkov E. (2000). Water uptake and relaxation processes in mixed unlimited swelling hydrogels. Int J Pharm, 209:45–56.
  • Siepmann J, Podual K, Sriwongjanya M, Peppas NA, Bodmeier R. (1999). A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. J Pharm Sci, 88:65–72.
  • Li CL, Martini LG, Ford JL, Roberts M. (2005). The use of hypromellose in oral drug delivery. J Pharm Pharmacol, 57:533–546.
  • Li S, Lin S, Daggy BP, Mirchandani HL, Chien YW. (2003). Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Int J Pharm, 253:13–22.
  • Mitchell SA, Balwinski KM. (2007). Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets. Drug Dev Ind Pharm, 33:952–958.
  • Hiremath PS, Saha RN. (2008). Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release. Drug Deliv, 15:159–168.
  • Levina M, Rajabi-Siahboomi AR. (2004). The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. J Pharm Sci, 93:2746–2754.
  • Caraballo I. (2010). Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories. Expert Opin Drug Deliv, 7:1291–1301.
  • Campos-Aldrete ME, Villafuerte-Robles L. (1997). Influence of the viscosity grade and the particle size of HPMC on metronidazole release from matrix tablets. Eur J Pharm Biopharm, 43:173–178.
  • Guido S. (1995). Phase behaviour of aqueous solutions of hydroxypropylcellulose. Macromolecules, 28:4530–4539.
  • Wang C, Dong Y, Tan H. (2003). Study on lyotropic liquid-crystalline properties of trimethylsilyl hydroxypropylcellulose. Carbohydr Res, 338:535–540.
  • Braga SS, Gonçalves IS, Herdtweck E, Teixeira-Dias JJC. (2003). Solid state inclusion compound of S-ibuprofen in β-cyclodextrin: structure and characterization. New J Chem, 27:597–601.
  • Lotfipour F, Nokhodchi A, Saeedi M, Norouzi-Sani S, Sharbafi J, Siahi-Shadbad MR. (2004). The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matrices. Farmaco, 59:819–825.
  • Maderuelo C, Zarzuelo A, Lanao JM. (2011). Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release, 154:2–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.